- Home
- RY vs TMO Comparison
RY vs TMO Comparison
Compare RY & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RY | TMO |
|---|---|---|
| Founded | 1864 | 1956 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 242.4B | 216.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RY | TMO |
|---|---|---|
| Price | $168.35 | $625.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 19 |
| Target Price | $162.00 | ★ $637.78 |
| AVG Volume (30 Days) | 1.3M | ★ 2.2M |
| Earning Date | 02-26-2026 | 01-29-2026 |
| Dividend Yield | ★ 2.68% | 0.27% |
| EPS Growth | ★ 25.07 | 8.54 |
| EPS | 10.04 | ★ 17.32 |
| Revenue | ★ $44,415,504,717.00 | $43,736,000,000.00 |
| Revenue This Year | $16.04 | $4.33 |
| Revenue Next Year | $5.00 | $5.05 |
| P/E Ratio | ★ $16.67 | $36.19 |
| Revenue Growth | ★ 15.03 | 3.22 |
| 52 Week Low | $106.10 | $385.46 |
| 52 Week High | $174.61 | $643.99 |
Technical Indicators
Market Signals| Indicator | RY | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 53.61 | 59.71 |
| Support Level | $166.63 | $622.68 |
| Resistance Level | $169.94 | $643.99 |
| Average True Range (ATR) | 1.78 | 15.06 |
| MACD | -0.68 | 0.08 |
| Stochastic Oscillator | 51.62 | 62.83 |
Price Performance
Historical ComparisonAbout RY Royal Bank Of Canada
Royal Bank of Canada is one of the two largest banks in Canada, with around CAD 2.3 trillion in assets at the end of fiscal 2025. It is a diversified financial services company, offering personal and commercial banking, wealth management, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada and has dominant market shares. RBC also has wealth and capital market businesses in the US, UK, and other countries. RBC is a top 15 investment bank globally.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).